Publications by authors named "Nadin Pletz"

Claim this Profile
T
The novel PI3 kinase inhibitor, BAY 80-6946, impairs melanoma growth in vivo and in vitro.
Philine Schneider, Margarete Schön, Nadin Pletz, Cornelia S Seitz, Ningshu Liu

Exp Dermatol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional activation of Odf2/Cenexin by cell cycle arrest and the stress activated signaling pathway (JNK pathway).
Nadin Pletz, Anja Medack, Eva Maria Rieß, Kefei Yang, Zahra Basir Kazerouni

Biochim Biophys Acta· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor.
Nadin Pletz, Margarete Schön, Karl Ziegelbauer, Steffen Emmert, Ningshu Liu

Exp Dermatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Tillmann Schill, Michael P Schön, Nadin Pletz, Steffen Emmert, Margarete Schön

Exp Dermatol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Katharina Amschler, Michael P Schön, Nadin Pletz, Katrin Wallbrecht, Luise Erpenbeck

J Invest Dermatol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis